secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alignment Healthcare, Inc. (ALHC)
CIK:        0001832466
Form:       8-K
Filed at:   2025-05-01T23:59:59+00:00
Accession:  0001171843-25-002689
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alignment Healthcare Q1 revenue up 47.5% to $926.9M; raises 2025 guidance; CFO transition
--------------------------------------------------------------------------------

- Q1 revenue $926.9M (+47.5% YoY); MA membership ~217,500 (+31.7% YoY).
- Adjusted EBITDA $20.2M; net loss $(9.4)M; medical benefits ratio 88.4% on adjusted gross profit.
- Exceeded high-end of Q1 guidance on membership, revenue, adjusted gross profit and adjusted EBITDA.
- Raises midpoint of 2025 full-year outlook for membership, revenue, adjusted gross profit and adjusted EBITDA.
- CFO Thomas Freeman becomes Strategic Advisor to CEO; Jim Head appointed CFO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832466/000117184325002689/0001171843-25-002689-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832466/000117184325002689/f8k_050125.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-002689

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer